User menu

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

Bibliographic reference Salles, Gilles ; Seymour, John Francis ; Offner, Fritz ; López-Guillermo, Armando ; Belada, David ; et. al. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.. In: The Lancet, Vol. 377, no.9759, p. 42-51 (2011)
Permanent URL http://hdl.handle.net/2078.1/123998